These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8311738)

  • 1. [Efficacy of and tolerance to buspirone hydrochloride in the treatment of psychosomatic symptoms in clinical cardiology].
    Ramires JA; Solimene MC; Serrano Júnior CV; Mansur Ade P; Pileggi F
    Arq Bras Cardiol; 1993 Apr; 60(4):269-72. PubMed ID: 8311738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Buspirone in the treatment of Generalized Anxiety Disorders].
    Rzewuska M; Sobucka K
    Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone in major depression: a controlled study.
    Rickels K; Amsterdam JD; Clary C; Puzzuoli G; Schweizer E
    J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone in the long-term treatment of generalized anxiety disorder.
    Feighner JP
    J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D; Napoliello MJ; Schenk J
    Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone in the management of major depression: a placebo-controlled comparison.
    Fabre LF
    J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].
    Radmayr E; Koeppen D
    MMW Munch Med Wochenschr; 1977 Dec; 119(50):1623-6. PubMed ID: 23493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buspirone in clinical practice.
    Rickels K
    J Clin Psychiatry; 1990 Sep; 51 Suppl():51-4. PubMed ID: 2211569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible augmentation of antidepressant response by buspirone.
    Jacobsen FM
    J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety.
    Sramek JJ; Hong WW; Hamid S; Nape B; Cutler NR
    Depress Anxiety; 1999; 9(3):131-4. PubMed ID: 10356651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone in the treatment of posttraumatic stress disorder.
    Wells BG; Chu CC; Johnson R; Nasdahl C; Ayubi MA; Sewell E; Statham P
    Pharmacotherapy; 1991; 11(4):340-3. PubMed ID: 1923917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
    Abellán Alemán J; Martínez García JF; Merino Sánchez J; Gil Guillén V; Latorre Hernández J; Fernández Montero F; Navarro Lima A;
    An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.